This inverse correlation between high TET2 and 5-hmC on the one hand, and low PRAME expression on the other, is consistently observed at a whole-specimen level in melanoma clinical cohorts by IF and IHC for 5hmC, and by RNA-seq for TET2 (based on data in the TCGA and GTEx databases). The gene discussed is TET2; the disease is melanoma.